Drug trial aims to tame severe seizures in rare epilepsy
Disease control
Terminated
This study tested whether adding the drug lorcaserin to existing medications could better control convulsive seizures in people with Dravet syndrome, a rare and severe form of childhood epilepsy. It was a Phase 3 trial that enrolled 22 participants, comparing lorcaserin to a plac…
Phase: PHASE3 • Sponsor: Eisai Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC